These Top Stocks Are Rebounding: Should You Buy Before 2023?
Many top stocks are heading for annual declines. The bear market has weighed on investor sentiment, and the economic environment, in some cases, has hurt earnings. But among the stocks heading for declines this year, some are showing signs of a rebound.
Right now, I'm thinking of two top healthcare names: Moderna (NASDAQ: MRNA) and Intuitive Surgical (NASDAQ: ISRG). Both stocks have posted double-digit increases over the past three months. As you study this new momentum, you may wonder whether you should get in on these players before 2023. Let's find out.
Moderna has declined about 30% year to date. But the stock has rebounded more than 20% over the past three months. Let's look at what drove the losses and check out the reasons behind the recent increase.
Source Fool.com
